5-Lipoxygenase inhibitors – patent and literature activity during 2001 – 2004

Author： Pommery Nicole   Massingham Roy   Hénichart Jean-Pierre  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.1, 2006-01, pp. : 13-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE4 inhibitors 2001. Patent and literature activity 2000 - September 2001

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2002-01 ,pp. : 93-112

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a patent evaluation (WO2011161615)

By Buscató Estel.la   Proschak Ewgenij  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 843-846

Informa Healthcare

Access to resources Recommend Favorite

β-Lactamase inhibitors: a survey of the patent literature 2000 – 2004

By Phillips Oludotun A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 319-331

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in 5lipoxygenase inhibitors

By Julémont Fabien   Dogné Jean-Michel   Laeckmann Didier   Pirotte Bernard   Leval Xavier de  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite